The Food and Drug Administration (FDA) has granted approval for a novel imaging agent that can identify prostate cancer after it has spread to other regions of the body. According
Recent Posts
- Physical exercise associated with lower long-term incidence of anxiety
- New Dementia biomarkers found in blood could open doors to new therapies for Alzheimer’s disease
- 18-24 year olds found to be most at risk for obesity
- Maternal obesity linked to increased risk of colorectal cancer in offspring
- People previously hospitalized due to COVID-19 show significant decreases in cognition
Most Used Categories
- Medical News (136)
- World health (27)
- Neuroscience (26)
- Biotechnology (22)
- Featured (20)
- Cancer (16)
- Diet (10)
- Longevity (10)
- Pharmaceuticals (10)
- COVID-19 news (10)